{
  "content": "Shah S, Barakat AF, Saliba WI, et al. Recurrent Atrial Fibrillation After Initial Long-Term Ablation Success: electrophysiological Findings and Outcomes of Repeat Ablation Procedures. Circ Arrhythm Electrophysiol . 2018;11(4):e005785. doi:10.1161/CIRCEP.117.005785 \n\nEpstein AE, Olshansky B, Naccarelli GV, Kennedy JI, Murphy EJ, Goldschlager N. Practical Management Guide for Clinicians Who Treat Patients with Amiodarone. Am J Med . 2016;129(5):468–475. doi:10.1016/j.amjmed.2015.08.039 \n\nVamos M, Hohnloser SH. Amiodarone and dronedarone: an update. Trends Cardiovasc Med . 2016;26(7):597–602. doi:10.1016/j.tcm.2016.03.014 \n\nTouboul P, Brugada J, Capucci A, Crijns HJ, Edvardsson N, Hohnloser SH. Dronedarone for prevention of atrial fibrillation: a dose-ranging study.",
  "source": "https://pdfs.semanticscholar.org/8144/63bafca99ba37325c5ff5b8beec010b33efd.pdf?skipShowableCheck=true",
  "chunk_id": "b4651fba-7a15-4acd-a7a7-522ffae1f164",
  "similarity_score": 0.39938294887542725,
  "query": "atrial fibrillation recurrence rates maintenance therapy amiodarone beta-blockers long-term outcomes rhythm maintenance",
  "rank": 10,
  "title": "Comparison of efficacy and safety between dronedarone and amiodarone used during the blind period in patients with atrial fibrillation after catheter ablation",
  "authors": "Yihan Li, Tong Hu, Mingjie Lin, Qinhong Wang, Wenqiang Han, Jingquan Zhong",
  "year": "2023",
  "journal": "Clinical Pharmacology: Advances and Applications",
  "reference": "Li, Y., Hu, T., Lin, M., Wang, Q., Han, W., & Zhong, J. (2023). Comparison of efficacy and safety between dronedarone and amiodarone used during the blind period in patients with atrial fibrillation after catheter ablation. Clinical Pharmacology: Advances and Applications, 15, 113–123. https://doi.org/10.2147/CPAA.SXXXXXX",
  "doi": "10.2147/CPAA.SXXXXXX",
  "chunk_index": 67,
  "total_chunks": 84,
  "retrieved_at": "2025-07-24T21:58:13.326163"
}